Bayer logo-white

Bayer's Expert Mondays

Knowledge Sharing to Empower Your Innovation Journey

5 p.m. CET on select Mondays, July - December 2023

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health! 

Do you have that breakthrough innovation in healthcare but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

Bayer’s mission is to boost innovation in EMEA and bring it to the patients who need it most. We are looking to enable and support standout innovation in healthcare by providing cost-free mentorship and knowledge exchange.

Join Bayer's Expert Mondays, dedicated to topics that can support you, your innovation, and your start-up in its growth! Benefit from Bayer´s global expertise, network with fellow founders and the Bayer Pharma team, and ask your questions. Let´s Collaborate to Cure!
Please note: These sessions are not intended for service providers, consultants, IT providers, etc., but are limited to drug developers and researchers in healthcare who are seeking collaboration with big pharma and out-licensing opportunities later in their journey.

Please note that recordings will not be sent to those who did not attend live.

 Theme Date Topic
(mouse over for full description)
Bayer Expert
Growing your innovation or start-up

3 July

5 p.m. CEST

Alternative Financing Possibilities: Creative Ways to Bridge the 'Valley of Death'

Anett Müller

BD&L Director Early Valuation

17 July

5 p.m. CEST

Medical Need: A Definition Challenge to Shape Your Value Proposition

J.P. Kruse

BD&L Senior Director 

31 July

5 p.m. CEST

Gating Decisions and How to Take the Right Ones


Dr. Hartwig Hennekes

VP, Project Management Oncology 

4 Sept

5 p.m. CEST

Spotlight on the Public/EU Grant Landscape 

Ina Kunze

BD&L Director Funding EU

18 Sept

5 p.m. CEST

Your Roadmap through the EU Regulatory Jungle

Dr. Isabelle Stoeckert

VP, Head Regulatory Affairs EMEA

Dr. Gabriele Bräunlich

VP, Head Regulatory Affairs Strategy

25 Sept

5 p.m. CEST

Venture Capital, Investment Banks: Strategic Financial Investors like Big Pharma, what are they looking for?

Dr. Vishal Patel

Senior Director
BD&L Strategy

9 Oct

5 p.m. CEST

Why Early Market Access Planning is a Good Investment & 10-min. deep-dive on Cell & Gene 

Bastian Haß

Market Access Lead

Franziska Gröhl

Market Access Manager

Dr. Markus Frick

Market Access Cell & Gene  

16 Oct

5 p.m. CEST

How to Set Up a Credible Business Case

Anett Müller

BD&L Director Early Valuation 

23 Oct

5 p.m. CEST

Leaps @ Bayer: Funding the 10 Leaps

André Guillaume

Head of Brand & Community Engagement Leaps @ Bayer 

Preparing for Dealmaking

13 Nov

5 p.m. CET

Business Process of Due Diligence @ Big Pharma: Why do they need so many documents & what´s in it for you?

Dr. Anja Moews

Dr. Torsten Hertrampf

BD&L Due Diligence CoE

27 Nov

5 p.m. CET

How to Prepare a Non-Confidential Deck & Pitching Pitfalls to Avoid

Sebastian Karrer

Dr. Daniel Forler

BD&L Senior Directors

Successful Collaborations

6 Nov


Munich, Germany

Panel Session

Recipes for Successful Biotech & Big Pharma Partnerships

Speakers TBA

4 Dec

5 p.m. CET

How to Build and Maintain a Successful Partnership & Bayer's Partnership Models

Dr. Christoph Huwe

Dr. Hanna Eilken

Senior Directors, Alliance Management 


11 Dec

5 p.m. CET

Co.Lab Berlin: Bayer´s Incubator Program & Modality Platform

J.P. Kruse

Lead, Co.Lab Berlin


About Bayer's Collaborate To Cure Hubs

The Bayer Collaborate To Cure Hub EMEA organizes these knowledge-sharing sessions to boost and support innovation in the EMEA region. As the regional hub of Bayer Pharma’s Business Development & Licensing team, we also offer a partnering interface to Bayer’s global scouting teams.

Through the Collaborate To Cure Hubs, Bayer is looking for the best and brightest ideas and projects in their respective locations for collaborations, partnerships, in-licensing, co-development, and many other forms of collaboration.

Connect with us if you are interested in collaborating, and let’s collaborate to cure to bring innovation to patients!

Bayer Collaborate To Cure Hub EMEA

Collaborate To Cure Hubs | Bayer Global


Powered by